HEART TEST LABORATORIES INC's ticker is and the CUSIP is 42254E104. A total of 9 filers reported holding HEART TEST LABORATORIES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,653 | -71.0% | 69,607 | -38.3% | 0.01% | -67.6% |
| Q2 2023 | $102,133 | -33.9% | 112,854 | -27.9% | 0.04% | -43.9% |
| Q1 2023 | $154,594 | +13.7% | 156,630 | -3.2% | 0.07% | -14.3% |
| Q4 2022 | $135,932 | +353.1% | 161,844 | +547.4% | 0.08% | +305.3% |
| Q3 2022 | $30,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Astoria Strategic Wealth, Inc. | 81,995 | $34,930 | 0.01% |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | 69,607 | $29,653 | 0.01% |
| CHAPIN DAVIS, INC. | 55,000 | $23,430 | 0.01% |
| Tradition Wealth Management, LLC | 149,165 | $64 | 0.01% |
| Virtu Financial LLC | 25,620 | $11 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $24 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 42,316 | $18,327 | 0.00% |
| Citadel Advisors | 30,586 | $13,247 | 0.00% |
| HRT FINANCIAL LP | 19,878 | $8 | 0.00% |